These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6339926)

  • 21. [Hemodynamic evaluation of pindolol].
    Biffani G; Santini M
    Minerva Cardioangiol; 1976 Sep; 24(9):613-8. PubMed ID: 1012501
    [No Abstract]   [Full Text] [Related]  

  • 22. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 25. [LB-46 in the treatment of angina pectoris, arrhythmia and functional cardiac disorders].
    Latorre A; Lenti M; Calabrese P
    Minerva Cardioangiol; 1976 Sep; 24(9):619-24. PubMed ID: 1012502
    [No Abstract]   [Full Text] [Related]  

  • 26. LB-46 in cardiac arrhythmias.
    Bisht DB; Banerji K
    Indian Heart J; 1972 Jun; 24():Suppl 1:205-10. PubMed ID: 4667015
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of coronary insufficiency with beta receptor blocking agents].
    Wink K
    Med Monatsschr; 1975 Feb; 29(2):65-7. PubMed ID: 236488
    [No Abstract]   [Full Text] [Related]  

  • 28. On the importance of a central beta-adrenoceptor site in the antiarrhythmic activity of beta-blockers.
    Bhargava KP
    Indian Heart J; 1972 Jun; 24():Suppl 1:157-66. PubMed ID: 4147273
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of hypertension with a beta-adrenoceptor blocker. A multicentre trial with pindolol.
    Rosenthal J; Kaiser H; Raschig A; Welzel D
    Br J Clin Pract; 1979 Jun; 33(6):165-74, 181. PubMed ID: 393291
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of beta adrenergic blocking on the arrhythmias following coronary ligation in rat.
    Kenedi I; Losonci A
    Acta Physiol Acad Sci Hung; 1973; 44(3-4):247-57. PubMed ID: 4143381
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of a beta-adrenoceptor antagonist, pindolol, on human uterine smooth muscle.
    Ingemarsson I; Adaikan PG; Arulkumaran S; Kottegoda SR
    Gynecol Obstet Invest; 1987; 24(3):185-9. PubMed ID: 3692331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visken (LB-46) a double blind cross-over study in cardiac arrhythmias.
    Damany SJ; Bhatt GR
    Indian Heart J; 1972 Jun; 24():Suppl 1:211-2. PubMed ID: 4581429
    [No Abstract]   [Full Text] [Related]  

  • 34. [Calcium channel blockers. Review and attempt at classification].
    van Zwieten PA; Timmermans PB
    Rev Esp Cardiol; 1984; 37(5):322-9. PubMed ID: 6387828
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of arterial hypertension by pindolol].
    Guédon J; Lucsko M; Chaignon M
    Nouv Presse Med; 1976 Feb; 5(8):511-2. PubMed ID: 817263
    [No Abstract]   [Full Text] [Related]  

  • 36. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pindolol in arterial hypertension. Multicentric study with 15 mg. of Viskene (pindolol) in a single daily dose].
    Abetel G; Christeler P; Henry M; Karly M; Knobel P; Magnenat G; Morandi D; de Senarclens B; Terrier P
    Rev Med Suisse Romande; 1977 Aug; 97(8):367-72. PubMed ID: 929024
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of digitalis induced arrhythmias with LB-46 (Visken).
    Chaubey BS; Attal HC
    Indian Heart J; 1972 Jun; 24():Suppl 1:215-23. PubMed ID: 4667017
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)].
    Werning C
    Med Klin; 1973 Nov; 68(47):1559-63. PubMed ID: 4781097
    [No Abstract]   [Full Text] [Related]  

  • 40. A new beta-adrenergic blocking agent in cardiac arrhythmias.
    Tikare SK; Thaly KG; Gupta PS
    Indian Heart J; 1972 Jun; 24():Suppl 1:213-4. PubMed ID: 4667016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.